Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890099035
